---
figid: PMC11979264__fphar-16-1527316-g007
figtitle: Mechanisms by which Met inhibits HGHF-induced ferroptosis and DOP
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11979264
filename: fphar-16-1527316-g007.jpg
figlink: /pmc/articles/PMC11979264/figure/F7/
number: F7
caption: Overview of the mechanisms by which Met inhibits HGHF-induced ferroptosis
  and DOP. Met can attenuate HGHF-triggered ferroptosis, enhancing bone microarchitecture
  in DOP through the activation of the AMPK/Nrf2 signaling pathway
papertitle: Metformin attenuates diabetic osteoporosis by suppressing ferroptosis
  via the AMPK/Nrf2 pathway
reftext: Yanwei Liu, et al. Front Pharmacol. 2025;16(NA).
year: '2025'
doi: 10.3389/fphar.2025.1527316
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: metformin | diabetic osteoporosis | ferroptosis | osteoblast | Nrf2/AMPK
automl_pathway: 0.9702588
figid_alias: PMC11979264__F7
figtype: Figure
redirect_from: /figures/PMC11979264__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11979264__fphar-16-1527316-g007.html
  '@type': Dataset
  description: Overview of the mechanisms by which Met inhibits HGHF-induced ferroptosis
    and DOP. Met can attenuate HGHF-triggered ferroptosis, enhancing bone microarchitecture
    in DOP through the activation of the AMPK/Nrf2 signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FTH1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - GABPA
  - NFE2L2
  - SLC7A11
  - SLC3A2
  - GPX4
  - Met
  - Lipid
  - Cystine
  - Cysteine
  - GSH
  - GSSG
  - Osteoporosis
---
